Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology

Feb.13.2025
From January 29th to 31st, one of the world’s largest tobacco and e-cigarette trade shows, the Total Product Expo (TPE), took place in Las Vegas. Mylor bio Co.,Ltd (hereafter referred to as “Mylor Bio”) made its mark at the event, showcasing its FUNC series nicotine salts and flavor modification technologies, offering groundbreaking solutions to push the boundaries of e-cigarette technology.

[2Firsts Reporting from Las Vegas] From January 29th to 31st, one of the world’s largest tobacco and e-cigarette trade shows, the Total Product Expo (TPE), took place in Las Vegas. As a platform for technological innovation in the e-cigarette industry, TPE gathers global brands, distributors, and experts, serving as a crucial venue for product launches and technical discussions. Mylor bio Co.,Ltd (hereafter referred to as “Mylor Bio”) made its mark at the event, showcasing its FUNC series nicotine salts and flavor modification technologies, offering groundbreaking solutions to push the boundaries of e-cigarette technology.

 

About Mylor Bio:

 

Mylor bio Co.,Ltd., a global leader in the development and manufacturing of e-liquid products, was founded in 2019. With state-of-the-art automated production lines and stringent quality control systems, Mylor Bio has rapidly established itself as an industry benchmark. The company operates a modern 5,000 square meter manufacturing facility, achieving an automation rate of 80%. Well-equipped with cutting-edge analysis instruments, such as GC, GC-MS, HPLC, and ICP-MS.With the support of a professional R&D team consisting of over ten experienced flavorists, Mylor Bio has successfully developed over 30,000 e-liquid formulas. The products are exported to key global markets including Europe, North America, the Middle East, Southeast Asia, and Russia.

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Mylor Bio Certification | Image Source: Mylor Bio

 

In the future, Mylor Bio will become an innovative pioneer in the industry through continuous technological advancements and an open collaboration approach, with a more forward-thinking vision and scientific practices.

 

FUNC Series Nicotine Salts: Precision Sensory Delivery  and Personalized Experience

 

Nicotine is the primary active ingredient in e-cigarettes, with the majority of it remaining in the aerosol as nicotine salts.. Nicotine salts are smoother and less harsh, allowing for a higher inhalable nicotine concentration.


Mylor Bio, drawing on years of customer service experience and market research, has recognized the diverse demands of different consumer groups regarding the sensation of nicotine. Leveraging the release patterns and absorption mechanisms of nicotine, Mylor Bio has innovatively launched the FUNC series nicotine salts to meet diverse needs.

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
FUNC Series Nicotine Salts Product at TPE Booth

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
FUNC Series Nicotine Salts Product at TPE Booth

 

FUNC Series Nicotine Salts Features:

 

· Precise Sensory Delivery: The FUNC series nicotine salts are designed to precisely target the head, throat, and chest areas, addressing a variety of preferences for headrush, throat hit, and chest kick sensations.

· Variety of Options: Including H-nicotine salt, T-nicotine salt, and C-nicotine salt.

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Diagram showing the partitioned effects of FUNC series nicotine salts | Image Source: Mylor Bio

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Sensory characteristics comparison between three nicotine salts and nicotine benzoate | Image Source: Mylor Bio

 

Compared to nicotine benzoate, H-nicotine salt's headrush intensity and onset speed increased by 43% and 25%, respectively; T-nicotine salt's throat hit improved by 43%; C-nicotine salt's chest kick increased by 67%.

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Comparison of market appeal between three nicotine salts and nicotine benzoate | Image Source: Mylor Bio

 

Compared to nicotine benzoate, the consumer liking for H-nicotine salt, T-nicotine salt, and C-nicotine salt increased by 42%, 25%, and 46%, respectively. The willingness to use again increased by 66%, 25%, and 33%.

 

Flavor Modification Solutions: Improving E-Liquid Flavor Profile

 

Beyond nicotine salts, flavor profile is another key factor in consumer choice of e-cigarettes. At TPE, Mylor Bio showcased its flavor modifiers, including:

· Sweeteners: Enhancing the natural sweetness, customized for ceramic core devices.

· Acidulants: Maximizing the freshness of fruit flavors.

· Cooling Agents: Precisely regulating the cooling effect’s target areas.

· Humectants: Enhancing hydration sensation and smoothness

 

Mylor Bio: Reshaping the Future of the Industry through Technological Innovation

 

At this year’s TPE, Mylor Bio’s booth attracted many international buyers. Ms. Lin, Sales Manager of Mylor Bio, shared:
“During this exhibition, we presented our latest nicotine salt series products, which received high recognition from industry professionals. We have already reached initial cooperation intentions with several globally renowned brands.”

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Visitors at the TPE exhibition show interest in Mylor Bio’s nicotine salt technology

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Visitors at the TPE exhibition show interest in Mylor Bio’s nicotine salt technology

 

John, an e-cigarette brand owner from the United States, expressed, “Mylor Bio's nicotine salt technology is indeed impressive. The innovations in taste are refreshing, especially the precise nicotine delivery technology combined with multiple flavor modification solutions which have broken new ground in flavor details. This multi-layered sensory experience is exactly what the market needs.”

 

 

Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.
Sep.18
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Product | JT Refreshes Ploom CUBE Design and Expands Japan Retail Distribution, Targeting Younger Men and Female Users
Product | JT Refreshes Ploom CUBE Design and Expands Japan Retail Distribution, Targeting Younger Men and Female Users
Japan Tobacco (JT) launched a refreshed Ploom CUBE design in Japan on September 8, 2026, with broader convenience-store and tobacco-retail distribution planned from October 13. The updated device retains the existing Rounded Cube form and heating platform while replacing four previous body colors with Pebble White and Cobalt Black. JT is also introducing new Front Panels and Fabric Back Covers, although the new accessories are not compatible with the previous Ploom CUBE design. The company says the update is intended to broaden appeal among younger male and female users.
Sep.09
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives